|
|||||
|
|
HDAC inhibitors: clinical update and mechanism-based potential |
|
| Authors: | Glaser Keith B |
| Affiliation: | Department of Cancer Research, R47J-AP9, Abbott Laboratories, Abbott Park, IL 60064-6121, USA. keith.glaser@abbott.com |
| Abstract: | |
| Keywords: | Histone deacetylase inhibitors Chromatin modification Epigenetic regulation Vorinostat Belinostat Romidepsin LBH589 MGCD0103 MS-275 |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |